Abstract
Fragment-based drug discovery (FBDD) needs a biophysical assay to complement, or even replace, biochemical screening. NMR is the best choice for this because NMR delivers many different types of data that impacts medicinal chemistry decisions. There are a multitude of different NMR methods which can be employed to these ends. The choice of which method to use will be different for every need. We discuss the different methods, the data they produce, and how they are best utilized in a FBDD setting.
Keywords: NMR, Fragment, Screening, protein-based, ligand-based
Current Topics in Medicinal Chemistry
Title: Practical Aspects of NMR-based Fragment Discovery
Volume: 7 Issue: 16
Author(s): Edward R. Zartler and Huaping Mo
Affiliation:
Keywords: NMR, Fragment, Screening, protein-based, ligand-based
Abstract: Fragment-based drug discovery (FBDD) needs a biophysical assay to complement, or even replace, biochemical screening. NMR is the best choice for this because NMR delivers many different types of data that impacts medicinal chemistry decisions. There are a multitude of different NMR methods which can be employed to these ends. The choice of which method to use will be different for every need. We discuss the different methods, the data they produce, and how they are best utilized in a FBDD setting.
Export Options
About this article
Cite this article as:
Zartler R. Edward and Mo Huaping, Practical Aspects of NMR-based Fragment Discovery, Current Topics in Medicinal Chemistry 2007; 7 (16) . https://dx.doi.org/10.2174/156802607782341055
DOI https://dx.doi.org/10.2174/156802607782341055 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Book Reviews: Planting Seeds, Practicing Mindfulness with Children
Adolescent Psychiatry The Yin and Yang of CD4+ Regulatory T Cells in Autoimmunity and Cancer
Current Medicinal Chemistry Hypoxic Preconditioning Increases Blood-Brain Barrier Disruption in the Early Stages of Cerebral Ischemia
Current Neurovascular Research Synthesis of Dihydropyridines: Patented Catalysts and Biological Applications
Recent Patents on Catalysis (Discontinued) Incretin Analogues that have been Developed to Treat Type 2 Diabetes Hold Promise as a Novel Treatment Strategy for Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Targeting the Fatty Acid Transport Proteins (FATP) to Understand the Mechanisms Linking Fatty Acid Transport to Metabolism
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Treatment of Internet Addiction in Patient with Panic Disorder and Obsessive Compulsive Disorder: A Case Report
CNS & Neurological Disorders - Drug Targets The Use of TNF Family Ligands and Receptors and Agents which Modify their Interaction as Therapeutic Agents
Current Drug Targets Brain Angiotensin and Cardiovascular Reactivity to Negative and Positive Emotional Stress
Current Hypertension Reviews Mitochondrial Dynamics and Proteins Related to Neurodegenerative Diseases
Current Protein & Peptide Science Reductive Stress: A New Concept in Alzheimer’s Disease
Current Alzheimer Research Systematic Review of the Reliability and Validity of Translated Interview Measures of Psychotic Symptoms
Current Psychiatry Reviews Possibilities within Acceptance and Commitment Therapy for Approaching Moral Injury
Current Psychiatry Reviews Joint Application of <i>Magnetic Resonance Imaging</i> and Biochemical Biomarkers in Diagnosis of Multiple Sclerosis
Current Medicinal Chemistry ‘Hot’ Cognition in Major Depressive Disorder: A Systematic Review
CNS & Neurological Disorders - Drug Targets Targeting SphK1 as a New Strategy against Cancer
Current Drug Targets Recent Inventions on Receptor Tyrosine Kinase RET Modulation
Recent Patents on Biotechnology Treponema, Iron and Neurodegeneration
Current Alzheimer Research Caffeine as a Lead Compound for the Design of Therapeutic Agents for the Treatment of Parkinson’s Disease
Current Medicinal Chemistry PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System
Current Stem Cell Research & Therapy